TRANSBIO SUDOE Project
Sponsored by the INTERREG IV B SUDOE program TRANSBIO SUDOE is a transnational cooperation project dedicated to innovation in life sciences in South-West of Europe. TRANSBIO SUDOE involves research laboratories, companies, technological platforms, competitiveness clusters and technological transfer offices (TTOs) from 8 Southern European regions in the field of biotechnologies and health: Midi-Pyrénées, Aquitaine, Languedoc-Roussillon, Lisbon, Barcelona, Valencia, Balearic Islands and Galicia. The TRANSBIO SUDOE project was built on the scientific, technological and educational potential of the area, and is the continuation of INTERBIO, a successful project financed by the INTERREG SUDOE program during the 2009-2012 period.
University Paul Sabatier, Toulouse III
Officially founded in 1969, University Toulouse III, Paul Sabatier (UPS) is one of the biggest universities in France. It offers a wide range of courses in science, technology, health, and human and social sciences. Each year, it welcomes 28.000 students and awards more than 11.000 degrees and diplomas. This campus is 31.987 students, 2.609 teachers and researchers and 1.980 staff. The pole “Life Sciences” is highly structured around excellence networks with complementary skills. It includes more than 1.200 permanent staff members in 20 mixed research and services units, 11 welcoming teams, 2 university laboratories and 5 federative structures, whose work covers the whole of the thematic fields of biology. The structuration of this cluster was impulsed by the creation, more than 10 years ago, of a GENOTOUL network with a view to setting up powerful high technology platforms for the whole scientific community. Toulouse has also been a leader in the field of training biology doctoral students, by the creation of one of the first Biology Health Biotechnology doctoral schools whose organization has been reproduced later on in other universities.
CAPTOR Project – Investissement d’Avenir
The CAPTOR project (Cancer Pharmacology of Toulouse Oncopole and Region) is one of the two French PHUC’s (Pôle Hospitalo-Universitaire du Cancer) and has been bearer of the program “Investing for the Future”. CAPTOR is the federative project for the Toulouse Oncopole and benefits from the skills and experiences of Toulouse III – Paul Sabatier University, CHU in Toulouse, Institut Claudius Regaud, Inserm, CNRS, and industrials partners like Laboratoires Pierre Fabre or Sanofi. CAPTOR has incorporated the three main dimensions of the universal fight against cancer (care, research and education) with four priority areas: innovation (WP1), drug evaluation (WP2), social pharmacology (WP3) and education (WP4).
INNABIOSANTE Foundation – Toulouse Cancer
INNABIOSANTE Foundation is a research foundation created by 5 worldwide private companies (Amgen – GSK – Pierre Fabre – Siemens – Total) involved in research and innovation, which has been state-approved May 5th 2006, with a special endowment of ANR, the French agency for research. The aim of the Foundation is to define, promote and finance cooperative actions to develop research and industry in the life sciences and especially in oncology by supporting the highly innovative areas that are: Nano & Bio & Information Technologies and also Radiotherapy and Imaging techniques (“NBI Tech 2 Life”). INNABIOSANTE is based on the Oncopole, in Toulouse, which is a campus, unique in Europe, that brings together on a single site public and private research, academic organizations, industry including pharmaceutical leaders and SMEs, medical and clinical expertise. These actors are committed to working together to achieve a single goal: more effectively fight cancer. By co-organizing the Summer School on Medicines since the first edition, INNABIOSANTE shows its involvement in multidisciplinary education dedicated to students in life sciences and health, but also in technological sciences.
University of Bordeaux
The University of Bordeaux is a major multidisciplinary European University, with a good national reputation and a strong international orientation. It prides to render its knowledge and skills accessible to a broad public and focuses its research and education on societal issues. It is a key player in the innovation strategy of the Aquitaine region and ranks as the 3rd French university outside Paris. The university operates in a rather lateral organization with colleges for education and departments for research. It houses nearly 3000 teachers and researchers in disciplines such as archeology, biology, chemistry, earth and environmental sciences, human and social sciences, languages, law, mathematics, medical and paramedical sciences and physics. It offers a total of 700 different degrees to near 50,000 students.
University of Montreal
Founded in 1878, the University of Montreal, with its two affiliated schools, the École Polytechnique and the HEC Montréal, is now the largest university in Quebec and the second largest in Canada, with over 64.000 students, including nearly 8.000 from around the world, and more than 11.000 diplomas awarded at every university level each year. Deeply rooted in Montreal and dedicated to its international mission, the University of Montreal is one of the top universities in the French-speaking world and is ranked 92nd on the list of top international institutions by the prestigious QS World University Rankings. The Faculty of pharmacy at University of Montreal is one of the largest faculties of pharmacy in Canada. In 2014, nearly 1.000 students were enrolled in undergraduate studies and more than 250 students were pursuing graduate studies.
University Drug Research Group (GRUM)
The University Drug Research Group (GRUM) was established in November 2004 by the Montreal University researchers in order to develop and support transdisciplinary research, researcher training and technology transfer relating to drug discovery, development and evaluation. It will be a hub for developing and increasing collaborative undertakings and exchanges between scientists exploring all aspects of drug discovery and development, including evaluation of how drugs affect population health.
Biocat is the organization that coordinates, dynamizes and promotes biotechnology, biomedicine and medical technology sector in Catalonia. It is fostered by the Government of Catalonia and the Barcelona City Council and, since it was created in 2006, has included companies and organizations from the sector (research centres, hospitals, universities…) in its governing bodies. Biocat works to achieve the following goals:
- Facilitate relationships and synergies among members of the BioRegion of Catalonia.
- Drive the sector to make it an economic engine in the country.
- Promote the sector on an international level.
- Improve the public’s knowledge and perception of biotechnology.
Barcelona Science Park
The Barcelona Science Park is a meeting point where university, business and society come together. Its objective is to promote innovation, particularly in the life sciences. Founded by the University of Barcelona in 1997, it was the first science park in Spain and is an international point of reference today in the promotion of innovation, with more than 2.000 professionals working there. The Barcelona Science Park has as its goals:
- To potentiate quality research with the support of a wide range of technologies
- To revitalise the relation between university and business
- To promote the creation of new companies and institutions
- To further the science-society dialogue and encourage careers in science
At present the park is home to 3 research institutes, 75 companies, an incubator for biotechnology companies and a wide range of research support technology. In addition, it organizes more than 120 activities for the promotion of scientific culture and new careers in science, in which close to 6.000 people participate each year.
CataloniaBIO is the Catalan Association of Biotechnology Companies, an initiative of business executives and entrepreneurs in the biotechnology industry, with the aim of bringing together all the Catalan companies with interests in the sector. The association offers to their members a platform for efficient and inclusive participation to define the framework of the sector and influence policies designed by the Government of Catalonia and its economic development agencies. CataloniaBIO represents the interests of biotech Catalan companies in front of politicians and decision-makers.
University of Barcelona
The UB is the top public university in Catalonia due to its size of student population, 74,000, and its course offering. It is also the top Spanish university in scientific production, so it is the main university research centre in Spain and one of the most important in Europe, as it is proved by its number of research programmes and the excellence it has attained.
The UB has a prominent position in the most prestigious international rankings: it is the only Spanish university which is among the 200 best worldwide universities in 25 out of 30 subject areas, according to the QS World University Rankings 2014 by Subject, and it holds the national top position in Leiden Ranking and URAP (it ranks 94th in the world ranking).
The University of Barcelona is member of the most important international excellence university networks, such as the League of European Research Universities. It has overseen the creation of two campuses of international excellence: the Barcelona Knowledge Campus (BKC) and the Health University of Barcelona Campus (HUBc). It has assimilated their goals as its own to increase competitiveness; these goals include the attraction of academic and research talent, full internationalisation, the enhancement of teaching quality and scientific quality, and an increase in the transfer of knowledge generated at the university to wider society.
Foundation InnDea Valencia
The InnDEA Valencia Foundation is an entity promoted by the City Council of Valencia whose aim is to support and promote city’s development through innovation in its different aspects. All the projects carried out by the Foundation aim to promote urban development and innovation in the interest of Valencian citizens in order to improve their life quality. InnDEA Valencia is developing its activities over a business system, which promotes innovation in the productive areas of the city of Valencia. For TRANSBIO SUDOE project, InnDEA Valencia is supported by VIT Salud, a cooperation network for the promotion and transfer of technology and applied knowledge in the field of Sciences and Health Technologies. VIT Salud comprises over 180 members among companies, research foundations for hospitals, research units of universities, bodies supporting innovation, research centres and technological institutes.
University of the Balearic Islands
The University of the Balearic Islands, heir to the ‘Universitat Lul·liana de Mallorca\’, was created in 1978; the first of the democratic era. Since then, this public institution of higher education has travelled the road that has led it to increasingly higher standards of academic quality and social responsibility. The University of the Balearic Islands is rooted in our land yet it is also universal, open to the world; it holds true to the principles of providing services and of collaborating with social and business actors, as well as with sustainability and respect for the environment. Thereby, it has become a key institution for the future and the backbone of our islands, and we would like it to continue to be a lever of social, cultural and economic progress; a lever supported by teaching and scientific excellence. Bearing in mind, at all times, that the culture of excellence must impregnate all the university activities, we have focused our efforts on these four axes: constant improvement of teaching, both classroom and virtual; staying at the cutting edge of research excellence; offering a cultural and social projection that impregnates every corner of our islands; and fomenting the internationalization of university activity, covering, through exchanges, teaching, research, innovation and administrative activities.
BIOIB Biotech Cluster of the Balearic Islands
The Balearic Islands Biotechnological and Biomedical cluster, BIOIB, started as a initiative of the Govern de les Illes Balears (Balearic Islands government) and “Balearic Association of biotechnology companies”, constituted by companies in which technological innovation plays a fundamental role in their competitive strategy. BOIB’s main objective is to increase and strengthen, at long term, the Balearic Island’s economy competitiveness, boosting those sectors recognised as a strategic and a top priority for the world’s most developed economies, and which contribute to the economic development of the Balearic Islands.
Campus Vida (Life Science Campus) is a collaborative ecosystem where the researchers, entrepreneurs, companies and institutions work together to shape a competitive bio cluster by promoting academic, scientific and entrepreneurial excellence in Galicia’s bio sanitary and biotechnological sector. It has been qualified in 2009 as an International Campus of Excellence by the Spanish Ministries of Education and Science and Innovation. It is led by the University of Santiago de Compostela (USC). Among our regional partners we highlight the Health Research Institute of Santiago de Compostela (IDIS) and the Galician Biotechnology Companies Cluster which are as well associated partners of TRANSBIO.